文献速递中医骨伤中药与中成药合理使用

杜仲丸靶向SLIT3耦联成骨与血管生成促进骨质疏松性骨折愈合

Protective effect of Du-Zhong-Wan against osteoporotic fracture by targeting the osteoblastogenesis and angiogenesis couple factor SLIT3.
PubMed 文献 · J Ethnopharmacol · 2022-05-29

杜仲丸由杜仲和续断按1:1组成,基于补肾壮骨理论。研究在去卵巢加股骨骨折小鼠中观察杜仲丸作用,发现其改善骨组织形态、促进骨痂形成、提高力学强度和H型血管生成,并增加SLIT3水平,机制可能与SLIT3耦联成骨与血管生成有关。

要点

  • 杜仲丸改善去卵巢骨折小鼠骨体积、骨小梁数目和骨形成率。
  • 杜仲丸增强骨折端H型血管生成并提高力学性能。
  • SLIT3可能是杜仲丸耦联成骨与血管生成的关键因子。

核心结论

  • 杜仲丸通过增强成骨和H型血管生成促进骨质疏松性骨折愈合,可能与诱导SLIT3产生有关。

研究设计与样本

  • C57BL/6小鼠去卵巢5周后行单侧股骨开放性横形骨折3周,期间给予杜仲丸,采集股骨和椎体分析。

主要发现

  • 杜仲丸显著改善去卵巢加骨折小鼠骨组织形态参数,包括骨体积、骨小梁数目和骨形成率增加,骨侵蚀面积减少。
  • 杜仲丸促进骨折骨痂形成,力学测试显示刚度和极限载荷显著提高。
  • 杜仲丸增强骨折端骨内膜和干骺端区域H型血管生成,CD31和EMCN水平增加。
  • 杜仲丸组SLIT3水平升高,BMSCs成骨过程中SLIT3也增加。

临床怎么用

  • 基于动物实验,杜仲丸可能作为骨质疏松性骨折的辅助治疗,但临床需进一步验证。

局限性

  • 研究为动物实验,样本量未报告,机制未通过基因敲除等直接验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

ETHNOPHARMACOLOGICAL RELEVANCE: Du-Zhong-Wan (DZW) is a traditional Chinese medicine (TCM) composed of Eucommia ulmoides Oliv. and Dipsacus asper Wall. ex C.B. Clarke in the ratio 1:1. Based on the TCM theory, DZW nourishes the kidney to strengthen the bones. The literature research revealed that DZW possesses anti-fatigue, anti-depressant, and anti-osteoporotic properties. However, the action and mechanism of DZW on osteoporotic fracture remains slightly unclear. AIM OF THE STUDY: To evaluate the pharmacological effect of DZW on ovariectomized mice with an open femoral fracture and reveal the underlying mechanism. MATERIALS AND METHODS: We conducted ovariectomy for 5 weeks, followed by unilateral open transverse femoral fracture for another 3 weeks in C57BL/6 mice; during this process, DZW was administrated. The femur bone and vertebra tissues were collected and analyzed by micro-computed tomography, histomorphometry, mechanical strength testing, immunohistochemistry staining, and qRT-PCR analyses. In addition, alkaline phosphatase (ALP) and Alizarin red S (ARS) staining were performed to determine the extent of osteoblastogenesis from bone marrow mesenchymal stem cells (BMSCs). Western blotting was performed to examine the protein expression. RESULTS: DZW treatment significantly improved the bone histomorphometric parameters in mice undergoing ovariectomy when combined with the femoral fracture, including an increase in the bone volume, trabecular number, and bone formation rate and a decrease in the bone erosion area. Simultaneously, DZW treatment histologically promoted fractured callus formation. Mechanical strength testing revealed significantly higher stiffness and an ultimate load after treatment with DZW. The angiogenesis of H-type vessels was enhanced by DZW, as evidenced by increased levels of CD31 and endomucin (EMCN), the H-type vessel endothelium markers, at the fractured endosteum and metaphysis regions. Relative to the osteoporotic fracture mice, the DZW treatment group showed an increased proangiogenic factor SLIT3 level. The increased level of SLIT3 was also recorded during the process of DZW-stimulated osteoblastogenesis from BMSCs. CONCLUSIONS: For the first time, we demonstrated that DZW promoted osteoporotic fracture healing by enhancing osteoblastogenesis and angiogenesis of the H-type vessels. This enhanced combination of osteoblastogenesis and angiogenesis was possibly related to the production of proangiogenic factor SLIT3 induced by DZW.

来源:J Ethnopharmacol,查看原文。版权归原作者所有。

引用

  1. Tian S, Zou Y, Wang J, et al. Protective effect of Du-Zhong-Wan against osteoporotic fracture by targeting the osteoblastogenesis and angiogenesis couple factor SLIT3. J Ethnopharmacol. 2022. PMID: 35649495. doi:10.1016/j.jep.2022.115399

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。